PT Medela Potentia Tbk (MDLA.JK) stock: key figures, P/E, revenue and dividend

Health Care · Indonesia

Price
185.00 IDR
Market cap
2.59 tn IDR
P/E (2025)
6.61
P/S (2025)
0.17
Dividend yield
6.81 %
Net margin
2.63 %
Return on equity (ROE)
12.92 %
Return on assets (ROA)
5.96 %

PT Medela Potentia Tbk financials

Fiscal year20242025
Revenue14.57 tn IDR14.89 tn IDR
Gross profit1.36 tn IDR1.44 tn IDR
Operating income466.33 bn IDR496.82 bn IDR
EBIT467.69 bn IDR525.31 bn IDR
Net income345.03 bn IDR392.27 bn IDR
Diluted EPS – continuing operations34.89 IDR27.99 IDR

Full history since 2021, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About PT Medela Potentia Tbk

PT Medela Potentia Tbk distributes and markets pharmaceutical and healthcare products, and medical devices in Indonesia and Cambodia. It also manufactures medical devices, including consumables and medical equipment for hospitals and laboratories. The company also processes medical device products; and digital platform and web portal activities for human use, as well as pharmaceutical products. In addition, the company develops GoApotik, a B2B2C platform for expanding its products to retailers, end consumers, and patients. PT Medela Potentia Tbk was founded in 2011 and is headquartered in Jakarta Selatan, Indonesia.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.